businesspress24.com - BIOLASE to Present at Lazard Capital Markets 5th Annual Medical Technology Snowbird Conference
 

BIOLASE to Present at Lazard Capital Markets 5th Annual Medical Technology Snowbird Conference

ID: 1197116

(firmenpresse) - IRVINE, CA -- (Marketwire) -- 02/14/13 -- BIOLASE, Inc. (NASDAQ: BIOL), the world's leading dental laser manufacturer and distributor, announced today that Fred Furry, Chief Operating Officer and Chief Financial Officer, will participate in the Lazard Capital Markets 5th Annual Medical Technology Snowbird Conference.

The event is being held from February 27 - March 1, 2013 at The Cliff Hotel, Snowbird Ski and Summer Resort in Snowbird, Utah. The conference format consists of a full day of one-on-one meetings and will not be webcast.

Institutional investors that wish to request a meeting with BIOLASE should contact Lazard Capital Markets.

About BIOLASE, Inc.
BIOLASE, Inc. is a biomedical company that develops, manufactures and markets and also distributes and markets dental ; products that are focused on technologies that advance the practice of dentistry and . The Company's laser products incorporate approximately 290 patented and patent-pending technologies designed to provide biologically clinically superior performance with less pain and faster recovery times. Its imaging products provide cutting-edge technology at competitive prices to deliver the best results for dentists and patients. BIOLASE's principal are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications, and a full line of dental imaging equipment. BIOLASE has sold more than 20,600 lasers. Other products under development address ophthalmology and other medical and consumer markets.

For updates and information on WaterLase and laser dentistry, find BIOLASE online at , Facebook at , Twitter at , and YouTube at .





For further information, please contact:
Lisa Wilson
In-Site Communications, Inc.
212-759-3929




Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  Reports of a Study Comparing Daxor's Direct Blood Volume Measurement With a Non-Invasive Hemoglobin Monitor in Critically Ill Surgical Patients
Align Technology Announces New Invisalign(R) Education Site
Bereitgestellt von Benutzer: MARKETWIRE
Datum: 14.02.2013 - 08:00 Uhr
Sprache: Deutsch
News-ID 1197116
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

IRVINE, CA


Phone:

Kategorie:

Dentistry


Anmerkungen:


Diese Pressemitteilung wurde bisher 120 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"BIOLASE to Present at Lazard Capital Markets 5th Annual Medical Technology Snowbird Conference
"
steht unter der journalistisch-redaktionellen Verantwortung von

BIOLASE, Inc. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von BIOLASE, Inc.



 

Who is online

All members: 10 562
Register today: 1
Register yesterday: 2
Members online: 0
Guests online: 84


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.